Literature DB >> 31630431

The Two Faces of Relaxin in Cancer: Antitumor or Protumor?

Sumera Rizvi1, Gregory J Gores1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 31630431      PMCID： PMC7089805          DOI： 10.1002/hep.30998

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  7 in total

Review 1.  Emerging roles for the relaxin/RXFP1 system in cancer therapy.

Authors:  Thatchawan Thanasupawat; Aleksandra Glogowska; Sai Nivedita-Krishnan; Brian Wilson; Thomas Klonisch; Sabine Hombach-Klonisch
Journal:  Mol Cell Endocrinol       Date:  2019-02-11       Impact factor: 4.102

2.  Relaxin expression from tumor-targeting adenoviruses and its intratumoral spread, apoptosis induction, and efficacy.

Authors:  Joo-Hang Kim; Young-Sook Lee; Hoguen Kim; Jing-Hua Huang; A-Rum Yoon; Chae-Ok Yun
Journal:  J Natl Cancer Inst       Date:  2006-10-18       Impact factor: 13.506

Review 3.  The biology and function of fibroblasts in cancer.

Authors:  Raghu Kalluri
Journal:  Nat Rev Cancer       Date:  2016-08-23       Impact factor: 60.716

Review 4.  Hepatic stellate cells: partners in crime for liver metastases?

Authors:  Ningling Kang; Gregory J Gores; Vijay H Shah
Journal:  Hepatology       Date:  2011-08       Impact factor: 17.425

5.  Nano-targeted relaxin impairs fibrosis and tumor growth in pancreatic cancer and improves the efficacy of gemcitabine in vivo.

Authors:  Deby F Mardhian; Gert Storm; Ruchi Bansal; Jai Prakash
Journal:  J Control Release       Date:  2018-10-02       Impact factor: 9.776

6.  Relaxin modulates human and rat hepatic myofibroblast function and ameliorates portal hypertension in vivo.

Authors:  Jonathan A Fallowfield; Annette L Hayden; Victoria K Snowdon; Rebecca L Aucott; Ben M Stutchfield; Damian J Mole; Antonella Pellicoro; Timothy T Gordon-Walker; Alexander Henke; Joerg Schrader; Palak J Trivedi; Marc Princivalle; Stuart J Forbes; Jane E Collins; John P Iredale
Journal:  Hepatology       Date:  2014-03-03       Impact factor: 17.425

7.  Relaxin gene delivery mitigates liver metastasis and synergizes with check point therapy.

Authors:  Mengying Hu; Ying Wang; Ligeng Xu; Sai An; Yu Tang; Xuefei Zhou; Jingjing Li; Rihe Liu; Leaf Huang
Journal:  Nat Commun       Date:  2019-07-05       Impact factor: 14.919
  7 in total
  1 in total

1.  The distribution of relaxin receptors in the anterior segment of primary open-angle glaucoma patients.

Authors:  Ofira Zloto; Alon Skaat; Ido Didi Fabian; Mordechai Rosner; Hana Ziv; Ari Leshno; Shlomo Melamed
Journal:  Indian J Ophthalmol       Date:  2020-10       Impact factor: 1.848
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.